Skip to main content
. 2016 Oct 26;7(48):78946–78957. doi: 10.18632/oncotarget.12935

Table 2. Malignant phenotype of S100A4 WT and mutants compared in the figures.

Assay WT NM CM CD
Migration-OECM1 +++ + ±
Migration-FaDu ++++ + ± +
Anchorage independent growth-OECM1 ++++ ++ + ±
Anchorage independent growth-FaDu ++++ ++ ± +
VimentinW ++++
Total 18 2 0 1

Positive and negative determine as high and low expression levels in comparison with the GFP, respectively.

W

immunoblotting assay